Facebook Twitter Tumblr Close Skip to main content
A Project of The Annenberg Public Policy Center

Democratic Convention Opening Night

Democratic Convention Opening Night

A quiet first night for fact-checkers. Only a few quibbles, including on the minimum wage, mail-in voting and Social Security payments.

Biden’s Greatest Hits

Biden’s Greatest Hits

A compendium of the top false and misleading claims by the Democratic presidential candidate.

Trump’s Missteps on COVID-19 Mortality

Trump’s Missteps on COVID-19 Mortality

President Donald Trump exaggerated Americans’ comparative success battling the coronavirus, falsely saying in a press briefing that the U.S. per capita death rate is lower than “most” of Western Europe. He also claimed a 9% decrease in COVID-19 fatalities over the past week, but the data do not show such a decline.

FactChecking Trump’s Weekend Press Briefings

FactChecking Trump’s Weekend Press Briefings

President Donald Trump made several false, misleading and exaggerated claims in press briefings he held Aug. 7 and 8 at Trump National Golf Club in Bedminster, New Jersey.

FactChecking Trump’s ‘Fox News Sunday’ Interview

FactChecking Trump’s ‘Fox News Sunday’ Interview

President Donald Trump’s extraordinary interview with “Fox News Sunday” host Chris Wallace, who frequently fact-checked the president in real time, contained a long list of false, misleading and unsubstantiated claims.

Trump Misleads on H1N1 Swine Flu Testing

Trump Misleads on H1N1 Swine Flu Testing

Deflecting attention from the rise in COVID-19 cases, President Donald Trump has repeatedly said the Obama administration “stopped testing” during the H1N1 pandemic. But the two viruses are very different, making the comparison misleading.

Navarro Doesn’t Give Full Picture On Hydroxychloroquine

Navarro Doesn’t Give Full Picture On Hydroxychloroquine

White House trade adviser Peter Navarro has promoted the “astonishing” results of an observational study that found hydroxychloroquine was associated with lower mortality for patients hospitalized for COVID-19. But the study has limitations, and multiple randomized controlled trials have found the drug is not beneficial to hospitalized patients.